Exo secures $200M toward commercializing ultrasound device – TechCrunch

Exo, pronounced "echo," raised a fresh cash infusion of $220 million in Series C financing aimed at commercializing its handheld ultrasound device and point-of-care workflow platform, Exo Works. The round was led by RA Capital Management, while BlackRock, Sands Capital, Avidity Partners, Pura Vida Investments and prior investors joined in. The new funding gives the Redwood City, California-based company over $320 million in total investments since the company was founded in 2015, Exo CEO Sandeep Akkaraju told TechCrunch. This includes a $40 million investment raised in 2020. Ultrasound machines can cost anywhere from $40,000 to $250,000 for low-end technology and into the millions for high-end machines.